Levofloxacino Dermogen

Levofloxacin, the active ingredient in Levofloxacino Dermogen, is a fluoroquinolone antibiotic presented as an oral tablet for systemic use. It treats bacterial infections of the respiratory tract, urinary system, skin and related tissues in adult patients. GNH USA supplies Levofloxacino Dermogen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacin is a broad‑spectrum antibacterial that acts on a variety of bacterial pathogens causing infections in several organ systems.

Respiratory tract infections: effective for community‑acquired pneumonia and acute exacerbations of chronic bronchitis. Urinary tract infections: used to eradicate uncomplicated and complicated urinary pathogens. Skin and soft tissue infections: treats cellulitis, wound infections and abscesses. Sinusitis: helps resolve acute bacterial sinus inflammation. Prostatitis: employed in chronic bacterial prostatitis management.

Levofloxacin may cause a range of adverse reactions, from mild to severe. Patients should be informed of common and serious possibilities.

Common Side Effects: - Nausea - Diarrhea - Headache - Dizziness

Serious or Rare Side Effects: - Tendon rupture or tendinitis - QT interval prolongation leading to arrhythmia - Severe allergic reactions such as anaphylaxis

Levofloxacino Dermogen requires careful use in specific clinical situations.

Assess renal function: adjust dose in patients with impaired clearance. Monitor for tendon pain: discontinue if signs of tendonitis or rupture appear. Avoid use in patients with known hypersensitivity to fluoroquinolones. Use with caution in patients with cardiac arrhythmias: monitor QT interval. Store at ambient temperature: keep in the original container, protect from moisture and light.

Levofloxacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: reduce levofloxacin absorption. - Warfarin: may increase anticoagulant effect and bleeding risk. - NSAIDs: heightened risk of central nervous system stimulation.

Moderate Interactions (Monitor Closely): - Other fluoroquinolones: additive QT prolongation risk. - Theophylline: may raise serum theophylline concentrations. - Glucocorticoids: increased likelihood of tendon rupture.